Logo image of ALVIO.PA

VALERIO TX (ALVIO.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ALVIO - FR0010095596 - Common Stock

0.1065 EUR
+0 (+0.47%)
Last: 12/29/2025, 7:00:00 PM
Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to ALVIO. ALVIO was compared to 81 industry peers in the Biotechnology industry. ALVIO has a bad profitability rating. Also its financial health evaluation is rather negative. ALVIO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

ALVIO had negative earnings in the past year.
In the past year ALVIO has reported a negative cash flow from operations.
In the past 5 years ALVIO reported 4 times negative net income.
In the past 5 years ALVIO always reported negative operating cash flow.
ALVIO.PA Yearly Net Income VS EBIT VS OCF VS FCFALVIO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

Looking at the Return On Assets, with a value of -64.61%, ALVIO is doing worse than 70.37% of the companies in the same industry.
Industry RankSector Rank
ROA -64.61%
ROE N/A
ROIC N/A
ROA(3y)-78.62%
ROA(5y)-48.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALVIO.PA Yearly ROA, ROE, ROICALVIO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0 0 0 0 0 0 0 0 0 0

1.3 Margins

Looking at the Gross Margin, with a value of 59.34%, ALVIO is in line with its industry, outperforming 53.09% of the companies in the same industry.
ALVIO's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ALVIO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.65%
GM growth 5Y-4.91%
ALVIO.PA Yearly Profit, Operating, Gross MarginsALVIO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

0

2. Health

2.1 Basic Checks

ALVIO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALVIO remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ALVIO has more shares outstanding
ALVIO has a worse debt/assets ratio than last year.
ALVIO.PA Yearly Shares OutstandingALVIO.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ALVIO.PA Yearly Total Debt VS Total AssetsALVIO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -3.64, we must say that ALVIO is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ALVIO (-3.64) is worse than 67.90% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3.64
ROIC/WACCN/A
WACC7.46%
ALVIO.PA Yearly LT Debt VS Equity VS FCFALVIO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M

2.3 Liquidity

ALVIO has a Current Ratio of 0.35. This is a bad value and indicates that ALVIO is not financially healthy enough and could expect problems in meeting its short term obligations.
ALVIO's Current ratio of 0.35 is on the low side compared to the rest of the industry. ALVIO is outperformed by 92.59% of its industry peers.
A Quick Ratio of 0.35 indicates that ALVIO may have some problems paying its short term obligations.
With a Quick ratio value of 0.35, ALVIO is not doing good in the industry: 91.36% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.35
ALVIO.PA Yearly Current Assets VS Current LiabilitesALVIO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 29.77% over the past year.
Looking at the last year, ALVIO shows a decrease in Revenue. The Revenue has decreased by -3.12% in the last year.
The Revenue for ALVIO have been decreasing by -16.01% on average. This is quite bad
EPS 1Y (TTM)29.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.14%
Revenue 1Y (TTM)-3.12%
Revenue growth 3Y-23.85%
Revenue growth 5Y-16.01%
Sales Q2Q%41.57%

3.2 Future

Based on estimates for the next years, ALVIO will show a decrease in Earnings Per Share. The EPS will decrease by -3.77% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y23.08%
EPS Next 2Y-3.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALVIO.PA Yearly Revenue VS EstimatesALVIO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2026 20M 40M 60M
ALVIO.PA Yearly EPS VS EstimatesALVIO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4 -0.4

1

4. Valuation

4.1 Price/Earnings Ratio

ALVIO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ALVIO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALVIO.PA Price Earnings VS Forward Price EarningsALVIO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALVIO is valued cheaper than 81.48% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.18
ALVIO.PA Per share dataALVIO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1

4.3 Compensation for Growth

ALVIO's earnings are expected to decrease with -3.77% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.77%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ALVIO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

VALERIO TX

EPA:ALVIO (12/29/2025, 7:00:00 PM)

0.1065

+0 (+0.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-01 2025-10-01
Earnings (Next)N/A N/A
Inst Owners9.03%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap52.06M
Revenue(TTM)1.83M
Net Income(TTM)-13.21M
Analysts34.29
Price Target0.01 (-90.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 28.45
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 12.18
EPS(TTM)-0.09
EYN/A
EPS(NY)-0.14
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS-0.02
TBVpS-0.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -64.61%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.34%
FCFM N/A
ROA(3y)-78.62%
ROA(5y)-48.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.65%
GM growth 5Y-4.91%
F-Score4
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 1.56
Cap/Depr 4.03%
Cap/Sales 21.15%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.35
Quick Ratio 0.35
Altman-Z -3.64
F-Score4
WACC7.46%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)20.63%
Cap/Sales(5y)14.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.14%
EPS Next Y23.08%
EPS Next 2Y-3.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.12%
Revenue growth 3Y-23.85%
Revenue growth 5Y-16.01%
Sales Q2Q%41.57%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y73.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year15%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y68.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y69.94%
OCF growth 3YN/A
OCF growth 5YN/A

VALERIO TX / ALVIO.PA FAQ

Can you provide the ChartMill fundamental rating for VALERIO TX?

ChartMill assigns a fundamental rating of 0 / 10 to ALVIO.PA.


What is the valuation status of VALERIO TX (ALVIO.PA) stock?

ChartMill assigns a valuation rating of 1 / 10 to VALERIO TX (ALVIO.PA). This can be considered as Overvalued.


Can you provide the profitability details for VALERIO TX?

VALERIO TX (ALVIO.PA) has a profitability rating of 0 / 10.


What is the expected EPS growth for VALERIO TX (ALVIO.PA) stock?

The Earnings per Share (EPS) of VALERIO TX (ALVIO.PA) is expected to grow by 23.08% in the next year.